Navigation Links
How chemotherapy drugs block blood vessel growth, slow cancer spread
Date:1/22/2009

Researchers at the Johns Hopkins University School of Medicine have discovered how a whole class of commonly used chemotherapy drugs can block cancer growth. Their findings, reported online this week at the Proceedings of the National Academy of Sciences Early Edition, suggest that a subgroup of cancer patients might particularly benefit from these drugs.

The anthracycline class of chemotherapeutics doxorubicin (Adriamycin), daunorubicin, epirubicin, idarubicin have been used for four decades to treat many types of cancer, including leukemia, lymphoma, sarcomas and carcinomas, The standard method of administration had been to use the highest tolerable dose every few weeks to kill all rapidly growing cells by preventing them from accurately copying their genetic material.

"But the late Judah Folkman discovered in 2000 that so-called metronomic treatment, giving patients lower doses of these drugs more frequently, can keep cancer growth at bay by blocking blood vessel formation, but the exact mechanism by which this occurred wasn't known," says Gregg L. Semenza, M.D., Ph.D., director of the vascular program at the Johns Hopkins Institute for Cell Engineering and a member of the McKusick-Nathans Institute of Genetic Medicine. "Now we've shown how it happens and what players are involved, which could help shape future clinical trials for patients with certain types of cancers."

Semenza and his team have long studied how the hypoxia-inducible factor, or HIF-1, protein helps cells survive under low-oxygen conditions. HIF-1 turns on genes that grow new blood vessels to help oxygen-starved cells, like those found in fast-growing solid tumors, survive.

To look for drugs that can prevent new blood vessel growth, the team tested more than 3,000 already FDA-approved drugs in the Johns Hopkins Drug Library for their ability to stop HIF-1 activity. Using modified liver cancer cells growing in low oxygen, the team treated cells wi
'/>"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Chemotherapy may be culprit for fatigue in breast cancer survivors
2. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
3. To evade chemotherapy, some cancer cells mimic stem cells
4. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
5. PET scans can accurately detect a breast tumors response to chemotherapy
6. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
7. Medicare modernization act did not change chemotherapy as feared
8. HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds
9. Cancer conflict with chemotherapy treatment
10. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
11. Jefferson researchers show chemotherapy and radiation together extend lung cancer patients lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)...ps to eliminate triggers, experts advise , ...t Scrooges, but people with allergies and asthma c...s and need to take special steps to prevent sneezi... of Allergy, Asthma and Immunology (ACAAI). , Thos...o decorate with artificial plants, but both live a...
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
... It is a fact that,Multi-Drug Resistant organisms ...trochemical medicines. According to the World Heal...s are responsible for needless increases,in hospit...ions to this growing problem., (Photo: http://ww...
...eflex Stock, the leading independent supplier of r...tions has today (October 1, 2008) launched a new c...uded in the new collections is Heritage Images, an...ommercially for the first time. , ...
...ed by researchers at Mayo Clinic shows that obese ... response to the weight loss drug sibutramine, whi...le or no weight. , The findings are published in ...sured the impact of two different dosage levels of...
...xoGen, Inc., a leader in the development of treatm...uries, announced today that the American Associati...stigious AATB accreditation. This accreditation af...ue. , ALACHUA, Fla. (Bus...
...Emergency Service,Center (DESC) is pleased to rele...e. DESC uses CHASERS to store and manage informati... Created by DESC, CHASERS is both proven and a wor...tains information on,over 70,000 clients served by...
...he second time in presidential debate history, a f...ale opponent. While Geraldine Ferraro broke new gr...male to be included as part of a major party ticke...evealing study by a University of Missouri researc...
Other Medicine News:Health News:Argentyn 23(R) Homeopathic First Aid Gel - Another World's First by Natural-Immunogenics Corp. for Healthcare Professionals 2Health News:Reflex Stock Launches Exciting New Editorial Image Collections to the Worldwide Publishing Industry 2Health News:Genes affect weight loss drug effectiveness 2Health News: AxoGen Awarded Accreditation from American Association of Tissue Banks : Decision Affirms AxoGen's Commitment to Safety and Ethicality in the Development and Distribution of AVANCE Nerve Graft for Treatment of Peripheral Nerve Injuries 2Health News: AxoGen Awarded Accreditation from American Association of Tissue Banks : Decision Affirms AxoGen's Commitment to Safety and Ethicality in the Development and Distribution of AVANCE Nerve Graft for Treatment of Peripheral Nerve Injuries 3Health News:Downtown Emergency Service Center Releases CHASERS, Free Software for Homeless Service Management and Beyond 2Health News:Downtown Emergency Service Center Releases CHASERS, Free Software for Homeless Service Management and Beyond 3Health News:Gender is a relative term in politics, MU study finds 2
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 1New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 2New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 3New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 4New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 5New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 6Hobby Lobby Selects Concentra to Open Health Center 62350 1Hobby Lobby Selects Concentra to Open Health Center 62350 2Hobby Lobby Selects Concentra to Open Health Center 62350 3US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 1US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 2US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 3
...eague,s historic Personhood Conference is featurin...earch and regenerative medicine. , , (Logo: htt...OGO ) , , Dr. Theresa Deisher, founder and CEO o...Pharmaceutical Institute, is speaking on over 17 y...ry, production and commercialization of human ther...
...x Foundation for Parkinson,s Research awarded abou... will test drugs already approved in other disease...son,s disease. Because both drugs being tested are...tential to move swiftly toward regulatory approval...ective in PD. , , One funded team will investigat...
Other Medicine Technology:Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials 2
... Orthosis Until now, laborious custom fabrication ...tability was limited and modifications in response...d cumbersome.,The GunSlinger evolved from two yea...ching hospital. This orthosis can be quickly adjus...
...gned for the functional management of grade I, II,...e-inflated aircell, the brace provides focused, pn... while supporting the arm and shoulder. A detachab...additional arm support and helps to unload the wai...
...to treat or help prevent lower extremity disorder..., foot drop, contractures and pressure necrosis at...s a comfortable wicking interface for the patient....ed into a vertical configuration when not needed o...
... ankle. This simple concept is the cornerstone of ... you lock the heel with our patent-pending Stablel...d comfort your patient will experience walking in ...the heel and supports the posterior aspect of the ...
Medicine Products: